Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-13-000915
Filing Date
2013-05-20
Accepted
2013-05-20 15:33:00
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 AMEXDRUG CORPORATION 10Q 2013-03-31 amexdrug.htm 10-Q 425644
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES amexdrugexh31-1.htm EX-31.1 13773
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES amexdrugexh31-2.htm EX-31.2 13999
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES amexdrugexh32-1.htm EX-32.1 7094
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES amexdrugexh32-2.htm EX-32.2 6693
  Complete submission text file 0001096906-13-000915.txt   1356217

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axrx-20130331.xml EX-101.INS 57015
7 XBRL TAXONOMY EXTENSION SCHEMA axrx-20130331.xsd EX-101.SCH 10369
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axrx-20130331_cal.xml EX-101.CAL 35229
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axrx-20130331_def.xml EX-101.DEF 5324
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE axrx-20130331_lab.xml EX-101.LAB 101685
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axrx-20130331_pre.xml EX-101.PRE 66488
Mailing Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211
Business Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211 3108550475
AMEXDRUG CORP (Filer) CIK: 0000045621 (see all company filings)

EIN.: 952251025 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10304 | Film No.: 13858134
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries